PREFER at DIA Europe 2022: Enhancing patient engagement

Patient Engagement is diverse. The PREFER session at DIA Europe 2022 will approach two different facets of patient engagement, covering both to patients’ involvement beyond study participation, as research partners in designing and returning results to participants, and the interest of patients and participants to join in and/or stay in a study.

Speakers include Kristin Bullok (Eli Lilly), Meredith Smith (Alexion), Maria Florez (Tufts Center For the Study of Drug Development), and Neil Bertelsen (HTAi) and the session will be chaired by Kristin Bullok with Isabelle Huys (KU Leuven). They will cover the emerging PREFER recommendations on stakeholder engagement from design to application of patient preference studies, plain language summaries and patient engagement in paediatrics, site staff diversity and its implications for patient engagement and recruitment, and patient engagement and patient experience data projects. 

Learn more

CONTACT US

X: @IMI_PREFER

LinkedIn

YouTube

  •  
  • Disclaimer: This website and its contents reflects the PREFER project's view and not the view of IMI, the European Union or EFPIA.
  •  

PREFER

The Patient Preferences in Benefit-Risk Assessments during the Drug Life Cycle (PREFER) project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 115966. This Joint Undertaking receives support from the European Union's Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA).